ELK4 and neoplasm: The decrease in H2S promotes a positive immune tumor microenvironment in colorectal cancer by lowering ENO1 persulfidation in regulatory T cells and ELK4 in CD8+ T cells, thereby enhancing the activity of anti-PD-L1 and anti-CTLA4 therapies in colon cancer35.